Strategic director

Karen Marie Ulshagen

Tel. +47 952 65 246

The area has five units participating in assessment work through:

  • providing scientific advice to pharmaceutical companies and the academia
  • assessing applications for clinical trials
  • coordinating participation in EU assignments
  • assessing applications for marketing authorisations and indication extensions
  • horizon-scanning/early detection of pharmaceuticals in the pipeline.
  • assessing single technology assessments (STA’s) and deciding which medicines should be publicly funded through the general reimbursement scheme
  • representing Norway in EMA’s scientific committees including CMDh and CMDv

Oppdatert: 16.10.2019

Publisert: 17.01.2017

​Fant du det du lette etter?